The Smooth Muscle Antibody (SMA) Titer measures the presence and concentration of autoantibodies that target proteins within smooth muscle cells, particularly actin. These antibodies are detected using indirect immunofluorescence and reported as a titer (for example, 1:40, 1:80, 1:160).
SMA testing plays a key role in the diagnostic workup of autoimmune hepatitis (AIH), a chronic inflammatory liver condition in which the immune system attacks hepatocytes. While SMA positivity alone does not confirm disease, higher titers—especially when combined with elevated liver enzymes, hypergammaglobulinemia (high IgG), and compatible liver biopsy findings—strongly support an autoimmune etiology.
Low-titer SMA results may occasionally be seen in other conditions, including viral hepatitis, primary biliary cholangitis, connective tissue diseases, or even transiently in healthy individuals. For this reason, interpretation always requires clinical context and correlation with additional laboratory markers such as ALT, AST, IgG, ANA, LKM-1, and liver imaging or biopsy when indicated.
Tracking SMA titers over time may also be useful in patients with known autoimmune hepatitis to assess immune activity alongside clinical symptoms and liver function trends.
Every lab result you’ve ever had, charted and explained.
Healthmatters is a tracker for your lab results. Upload a report from any lab, any country — every marker charted and explained.
Start with my report →All our content is backed by peer-reviewed studies, academic research, and trusted medical sources. We’re committed to accuracy and transparency — see our editorial policy for details.